Form4insider filings, from the source

SEC Form 4 · accession 0001209191-16-139304

AGIOS PHARMACEUTICALS, INC. · AGIO

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Period of report
Aug 29, 2016
Accepted (ET)
Aug 31, 2016 · 4:02 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001439222

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common stockF2Aug 29, 2016S627$37.81D110,913D
Common stockF2,F3Aug 29, 2016S625$37.81D110,943ISee footnote
Common stockF4Aug 30, 2016S627$36.81D110,286D
Common stockF4,F3Aug 30, 2016S625$36.81D110,318ISee footnote
Common stockF5holding———12,500ISee footnote
Common stockF6holding———12,500ISee footnote

Table II — derivative securities

No Table II lines on this filing.

Explanation of responses